Reuters: Regulatory News: CORRECTED-FDA studying deaths of two patients on Lilly's long-acting Zyprexa

Reuters: Regulatory News Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com

CORRECTED-FDA studying deaths of two patients on Lilly's long-acting Zyprexa Jun 18th 2013, 14:53 Tue Jun 18, 2013 10:53am EDT June 18 (Reuters) - The U.S. Food and Drug Administration on Tuesday said it was investigating deaths of two patients who died following injections with Eli Lilly and Co's long-acting treatment for schizophrenia, called Zyprexa Relprevv. The agency said the patients died 3 to 4 days after receiving an appropriate dose of the medicine. (Reporting by Ransdell Pierson; Editing by Gerald E. McCormick)

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions